Sajinker Kaur Luthra

Title: Sajinker Kaur Luthra: Innovator in Radiotracer Development

Introduction

Sajinker Kaur Luthra is a prominent inventor based in Amersham, GB. She has made significant contributions to the field of medical imaging, particularly in the development of novel radiotracers for Positron Emission Tomography (PET). Her work focuses on improving the detection and imaging of neuroendocrine tumors, which are critical for accurate diagnosis and treatment.

Latest Patents

Sajinker holds a patent for "Radiolabelled octreotate analogues as PET tracers." This invention describes novel radiotracers specifically designed for PET imaging of neuroendocrine tumors. The patent details the development of [18F]Fluoroethyltriazol-[Tyr3]Octreotate analogs, which target somatostatin receptors found on the cell surface of gastroenteropancreatic neuroendocrine tumors. Additionally, the patent outlines the intermediate and precursor compounds, pharmaceutical compositions, methods of making, and methods of using these novel radiotracers.

Career Highlights

Throughout her career, Sajinker has worked with esteemed institutions, including Imperial College and GE Healthcare Limited. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in medical imaging.

Collaborations

Sajinker has collaborated with notable colleagues such as Julius Leyton and Eric Ofori Aboagye. These partnerships have enhanced her research and development efforts, leading to innovative solutions in the medical imaging sector.

Conclusion

Sajinker Kaur Luthra's contributions to the field of radiotracers for PET imaging demonstrate her commitment to advancing medical technology. Her innovative work continues to impact the diagnosis and treatment of neuroendocrine tumors, showcasing the importance of research and collaboration in the medical field.